Tofersen, a New Treatment for A.L.S., Reverses Symptoms for Somenews2026-05-06T16:09:19+00:00May 6th, 2026|The New York Times|
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancernews2026-05-01T21:28:23+00:00May 1st, 2026|The New York Times|
4 Medications That May Increase Dementia Risknews2026-04-22T09:00:52+00:00April 22nd, 2026|The New York Times|
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancernews2026-04-22T03:48:00+00:00April 22nd, 2026|The New York Times|
6 medicamentos comunes que pueden reducir el riesgo de demencianews2026-04-19T09:04:11+00:00April 19th, 2026|The New York Times|
Iris Long, Scientific Mentor to AIDS Activists, Dies at 92news2026-04-17T19:56:21+00:00April 17th, 2026|The New York Times|
6 Common Medications That May Decrease Dementia Risknews2026-04-17T09:00:10+00:00April 17th, 2026|The New York Times|
Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectivenessnews2026-04-16T00:05:36+00:00April 16th, 2026|The New York Times|
F.D.A. Calls on Drug Developers to Publish Missing Data from Thousands of Trialsnews2026-04-13T18:08:49+00:00April 13th, 2026|The New York Times|
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billionnews2026-03-31T19:18:06+00:00March 31st, 2026|The New York Times|
